EQT Life Sciences

Venture fund

Stages: Series A, Series B, Growth
Cheque size: EUR 5M to EUR 60M
Based in: Netherlands
Focus: Pharma & Drug Discovery, Devices & Robotics, Health Data Infrastructure

EQT Life Sciences began as Life Sciences Partners, founded in 1988 in Amsterdam. EQT acquired the firm in 2022 and rebranded it as EQT Life Sciences, which has backed more than one hundred and fifty life sciences and health technology companies across Europe and beyond.

European life sciences and health technology growth investing.

Notable investments

Neko Health
Cortexyme
Nyxoah

Firm website

The journey

How EQT Life Sciences got here, step by step.

1988
Life Sciences Partners founded
LSP was founded in Amsterdam as a venture firm dedicated to life sciences investing.
1990s to 2010s
Three decades of European investing
LSP built a track record across biotech, medtech and life sciences companies in Europe.
2021
EQT announces the acquisition
EQT announced an agreement to acquire LSP, strengthening its position in healthcare investment.
2022
EQT Life Sciences formed
EQT closed the acquisition and introduced the rebranded EQT Life Sciences platform.
2023 to 2025
Portfolio passes 150 investments
EQT Life Sciences reported more than one hundred and fifty investments supporting new treatments and technologies.